Prevalence of human papilloma virus type 5 DNA in lesional and non-lesional skin scales of Italian plaque-type psoriatic patients: Association with disease severity

Clinical Microbiology and Infection

Volumn 11, Issue 1, 2005, Pages 47-51

  Prignano, G ^a   Ferraro, C ^a   Mussi, A ^a   Stivali, F ^a   Trento, E ^a   Bordignon, V ^a   Crescimbeni, E ^a   Salvati, G ^b   Degener, A M ^b   Ameglio, Franco ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

HPV 5; Human papilloma virus; Nested PCR; PASI score; Psoriasis

Indexed keywords

VIRUS DNA;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; GENDER; GEOGRAPHY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 5; ITALY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE; STATISTICAL SIGNIFICANCE; WART VIRUS;

HUMAN PAPILLOMA VIRUS; PAPILLOMAVIRUS;

EID: 13644256426     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.01040.x     Document Type: Article

References (24)

1. Favre M, Orth G, Majewski S,. Baloul S, Pura A, Jablonska S. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998; 110: 311-317.
2. de Villiers EM. Human papillomavirus infections in skin cancers. Biomed Pharmacoter 1998; 52: 26-33.
3. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131: 1312-1318.
4. Weissenborn SJ, Hopfl R, Weber F, Smola H, Pfister HJ, Fuchs PG. High prevalence of a variety of epidermodysplasia verruciformis associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol 1999; 113: 122-126.
5. Majewski S, Jablonska S, Favre M, Ramoz N, Orth G. Papillomavirus and autoimmunity in psoriasis. Immunol Today 1999; 20: 475-476.
6. Favre M, Majewski S, Noszczyk B et al. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 2000; 114: 404-407.
7. Friedewald WT. Cell state as affecting susceptibility to a virus. Enhanced effectiveness of the rabbit papillomavirus on hyperplastic epidermis. J Exp Med 1942; 75: 197-219.
8. Ramoz N, Rueda L-A, Bouadjar B, Favre M, Orth G. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17 qter in a region containing a psoriasis locus. J Invest Dermatol 1999; 112: 259-263.
9. Astori G, Lavergne D, Benton C et al. Human papillomavirus are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998; 110: 752-755.
10. Boxman ILA, Mulder LHC, Russel A, Bouwes Bavink JN, ter Green A, Schegget J. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol 1999; 141: 246-249.
11. Bonifati C, Ameglio F. Cytokines in psoriasis. Int J Dermatol 1999; 38: 241-251.
12. Majewski S, Jablonska S, Favre M, Orth G. Cytokine may favor a role for human papillomavirus in the pathogenesis of psoriasis. Arch Dermatol 2001; 137: 1373.
13. Mahe E, Bodemer C, Descamps V et al. High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis. Br J Dermatol 2003; 149: 819-825.
14. Fredrikson T, Patterson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1979; 157: 238-244.
15. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
16. Berkhout RJM, Tieben LM, Smits HL, Bouwes Bavink JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33: 690-695.
17. Forslund O, Antonsson A, Nordin P, Steinquist B, Hansson BG. A broad range of human papillomavirus types detected with general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999; 80: 2437-2443.
18. Struijk L, Bouwes Bavink JN, Wanningen P et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 2003; 121: 1531-1535.
19. Forslund O, Ly H, Reid C, Higgins G. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003; 149: 64-73.
20. Majewski S, Jablonska S. Possible involvement of epidermodysplasia verruciformis human papillomaviruses in the immunopathogenesis of psoriasis: a proposed hypothesis. Exp Dermatol 2003; 12: 721-728.
21. Arany I, Grattendick KG, Tyring SK. Interleukin-10 induces transcription of the early promoter of the human papillomavirus type 16 (HPV16) through the 5′-segment of the upstream regulatory region (URR). Antiviral Res 2002; 55: 331-339.
22. Dolei A, Curreli S, Marongiu P et al. Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein. J Gen Virol 1999; 80: 2937-2944.
23. de Villiers EM, Ruhland A. Do specific human papillomavirus types cause psoriasis? Arch Dermatol 2001; 137: 1373.
24. Jackson S, Storey A. E6 protein from diverse cutaneous HPV types inhibits apoptosis in response to UV damage. Oncogene 2000; 19: 592-598.